LeMaitre Vascular (LMAT)
(Real Time Quote from BATS)
$93.76 USD
+8.16 (9.53%)
Updated Aug 6, 2025 09:52 AM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, LeMaitre Vascular, Inc. has a market cap of $1.93B, which represents its share price of $85.60 multiplied by its outstanding shares number of 22.59M. As a small-cap company, LMAT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LMAT 93.76 +8.16(9.53%)
Will LMAT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LMAT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LMAT
LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
LMAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates
BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care
FitLife Brands (FTLF) Surges 13.1%: Is This an Indication of Further Gains?
Other News for LMAT
LMAT Upgraded to 'Outperform' by Barrington Research | LMAT Stock News
LeMaitre just upgraded at Barrington, here's why
LeMaitre Vascular declares $0.20 dividend
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...
LeMaitre raises 2025 revenue guidance to $251M with 15% organic growth as international launches accelerate